BR9913288A - Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóico - Google Patents
Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóicoInfo
- Publication number
- BR9913288A BR9913288A BR9913288-5A BR9913288A BR9913288A BR 9913288 A BR9913288 A BR 9913288A BR 9913288 A BR9913288 A BR 9913288A BR 9913288 A BR9913288 A BR 9913288A
- Authority
- BR
- Brazil
- Prior art keywords
- carnitine
- acetyl
- lipoic acid
- alpha
- antioxidant composition
- Prior art date
Links
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 title abstract 4
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 title abstract 3
- 229960002663 thioctic acid Drugs 0.000 title abstract 3
- 239000003963 antioxidant agent Substances 0.000 title abstract 2
- 230000003078 antioxidant effect Effects 0.000 title abstract 2
- 235000006708 antioxidants Nutrition 0.000 title abstract 2
- 235000019136 lipoic acid Nutrition 0.000 title abstract 2
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000000378 dietary effect Effects 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1998RM000566A IT1302307B1 (it) | 1998-09-01 | 1998-09-01 | Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil |
| PCT/IT1999/000268 WO2000011968A1 (en) | 1998-09-01 | 1999-08-19 | ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9913288A true BR9913288A (pt) | 2001-05-22 |
Family
ID=11406116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9913288-5A BR9913288A (pt) | 1998-09-01 | 1999-08-19 | Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóico |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6365622B1 (https=) |
| EP (1) | EP1112005B2 (https=) |
| JP (1) | JP4361215B2 (https=) |
| KR (1) | KR20010079699A (https=) |
| CN (1) | CN1315835A (https=) |
| AR (1) | AR022076A1 (https=) |
| AT (1) | ATE228312T1 (https=) |
| AU (1) | AU773424B2 (https=) |
| BR (1) | BR9913288A (https=) |
| CA (1) | CA2341973C (https=) |
| CZ (1) | CZ2001541A3 (https=) |
| DE (1) | DE69904208T3 (https=) |
| DK (1) | DK1112005T4 (https=) |
| EE (1) | EE200100113A (https=) |
| ES (1) | ES2188214T5 (https=) |
| HK (1) | HK1039730A1 (https=) |
| HU (1) | HU229165B1 (https=) |
| IL (1) | IL141435A0 (https=) |
| IS (1) | IS5850A (https=) |
| IT (1) | IT1302307B1 (https=) |
| MA (1) | MA25284A1 (https=) |
| NO (1) | NO20010954L (https=) |
| PL (1) | PL212737B1 (https=) |
| PT (1) | PT1112005E (https=) |
| SK (1) | SK2632001A3 (https=) |
| TN (1) | TNSN99163A1 (https=) |
| TR (1) | TR200100610T2 (https=) |
| WO (1) | WO2000011968A1 (https=) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6562869B1 (en) | 1999-09-23 | 2003-05-13 | Juvenon, Inc. | Nutritional supplement for increased energy and stamina |
| WO2001021208A1 (en) | 1999-09-23 | 2001-03-29 | Juvenon Corporation | Nutritional supplement for increased energy and stamina |
| CA2389623A1 (en) * | 1999-11-03 | 2001-05-10 | Juvenon, Inc. | Method of treating benign forgetfulness |
| US6664287B2 (en) * | 2000-03-15 | 2003-12-16 | Bethesda Pharmaceuticals, Inc. | Antioxidants |
| DE10036797A1 (de) * | 2000-07-28 | 2002-02-07 | Beiersdorf Ag | Verwendung von Kombinationen mit einem Gehalt an Carnitinen |
| CN1477958A (zh) * | 2000-10-31 | 2004-02-25 | 高露洁-棕榄公司 | 组合物及方法 |
| JP2010142237A (ja) * | 2000-10-31 | 2010-07-01 | Colgate Palmolive Co | 組成物及び方法 |
| US20020076470A1 (en) * | 2000-10-31 | 2002-06-20 | Colgate-Palmolive Company | Composition and method |
| US8669282B2 (en) | 2000-10-31 | 2014-03-11 | Hill's Pet Nutrition, Inc. | Companion animal compositions including lipoic acid and methods of use thereof |
| US6555573B2 (en) | 2000-12-21 | 2003-04-29 | The Quigley Corporation | Method and composition for the topical treatment of diabetic neuropathy |
| PL363426A1 (en) * | 2001-03-09 | 2004-11-15 | Societe Des Produits Nestle S.A. | Composition improving age-related physiological deficits and increasing longevity |
| SE0102380D0 (sv) * | 2001-07-02 | 2001-07-02 | Macronova Ab | Kräm för behandling av åldersförändringar i huden hos människa |
| US6923960B2 (en) | 2001-10-03 | 2005-08-02 | Vsl Pharmaceuticals Inc. | Antioxidant combination composition and use thereof |
| NZ533439A (en) * | 2001-12-19 | 2006-06-30 | The Quigley Corp | Methods for the treatment of peripheral neural and vascular ailments using flavonoid compositions |
| US20060127505A1 (en) * | 2002-01-16 | 2006-06-15 | David Haines | Anti-inflammatory formulations |
| EP1476440A4 (en) * | 2002-02-22 | 2005-06-01 | Albany College Of Pharmacy | METHODS AND COMPOUNDS USEFUL IN INHIBITION BY RADICAL AND / OR OXIDIZING AGGRESSION AND IN THE TREATMENT AND PREVENTION OF DISEASE |
| JP2006506361A (ja) * | 2002-10-11 | 2006-02-23 | クレアグリ， インコーポレイテッド | カルニチンおよび酸化防止ポリフェノールの治療用組合せ |
| US7083813B2 (en) | 2002-11-06 | 2006-08-01 | The Quigley Corporation | Methods for the treatment of peripheral neural and vascular ailments |
| DE10258239A1 (de) * | 2002-12-13 | 2004-06-24 | Degussa Ag | Formulierung enthaltend alpha-Liponsäure(-Derivate) als alleinigen Wirkstoff bei nichtchronischen alkoholinduzierten Intoxikationen |
| ITRM20020620A1 (it) * | 2002-12-13 | 2004-06-14 | Sigma Tau Ind Farmaceuti | Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa. |
| US20040265345A1 (en) * | 2003-06-30 | 2004-12-30 | Perricone Nicholas V. | Treatment of skin damage using acetyl carnitine and lipoic acid |
| US20050214413A1 (en) * | 2003-08-26 | 2005-09-29 | Mannatech, Inc. | Methods and compositions for modified release of nutritional supplements |
| US7999003B2 (en) * | 2003-08-26 | 2011-08-16 | Mannatech, Incorporated | Antioxidant compositions and methods thereto |
| EP1706146B1 (en) * | 2003-12-31 | 2013-08-21 | K-Pax Pharmaceuticals, Inc. | Nutrient compositions and use thereof for enhanced effectiveness of the immune system |
| US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
| US8569367B2 (en) * | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
| JP5138380B2 (ja) * | 2004-11-24 | 2013-02-06 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 動物における免疫応答を増大させる方法 |
| WO2006058278A2 (en) * | 2004-11-24 | 2006-06-01 | Hill's Pet Nutrition, Inc. | Methods for improving liver clearance of xenobiotic substances in an animal |
| US20090176864A1 (en) * | 2004-11-24 | 2009-07-09 | Hill's Pet Nutrition, Inc. | Methods For Improving Hepatic and Immune Function In An Animal |
| DK1830883T3 (da) | 2004-12-29 | 2013-11-25 | Hills Pet Nutrition Inc | Fremgangsmåde til at hæmme en nedgang i indlæring og/eller hukommelse hos dyr |
| US8148325B2 (en) * | 2004-12-30 | 2012-04-03 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
| US8252742B2 (en) * | 2004-12-30 | 2012-08-28 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
| JP5685362B2 (ja) * | 2005-04-26 | 2015-03-18 | シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ | 有痛性末梢糖尿病性神経障害の予防のためのアセチルｌ−カルニチン |
| EP1906912B1 (en) | 2005-07-14 | 2012-08-15 | Hill's Pet Nutrition, Inc. | Method for prolonging the life of animals |
| US8318954B2 (en) * | 2006-02-23 | 2012-11-27 | Nou Life Sciences, Inc. | Cleavable carnitine compound |
| CN101045048B (zh) * | 2006-03-27 | 2011-05-18 | 中国科学院上海生命科学研究院 | 线粒体营养素组合物的应用 |
| CN101057857B (zh) * | 2006-04-21 | 2011-05-18 | 中国科学院上海生命科学研究院 | 一种预防与改善帕金森氏症的组合物及其制法 |
| KR100811110B1 (ko) * | 2007-02-21 | 2008-03-06 | 주식회사 디피아이 솔루션스 | 수분산성 α-리포산 캡슐 조성물을 함유하는 어류의 면역력증강용 사료첨가제 및 그 사용방법. |
| US20080226696A1 (en) * | 2007-03-15 | 2008-09-18 | Ben Treadwell | Methods of improving learning abilities of aged companion animals |
| US20100255109A1 (en) * | 2007-08-06 | 2010-10-07 | Biogenics, Inc. | Stabilized antioxidant particles, composition comprising the same and method for preparing the same |
| KR20090014568A (ko) * | 2007-08-06 | 2009-02-11 | (주)바이오제닉스 | 코팅된 알파리포산 입자, 이를 포함하는 조성물 및 그 제조방법 |
| US20090054513A1 (en) * | 2007-08-22 | 2009-02-26 | Response Scientific, Inc. | Method of managing blood glucose levels, insulin levels and/or insulin receptor functionality in individuals with diabetes, polycystic ovarian syndrome and/or alzheimer's disease |
| US7943163B2 (en) * | 2007-08-22 | 2011-05-17 | Response Scientific, Inc. | Medical food or nutritional supplement, method of manufacturing same, and method of managing diabetes |
| KR100903549B1 (ko) * | 2008-07-29 | 2009-06-23 | 주식회사 카이로제닉스 | 균질한 결정성의 아세틸-ｌ-카르니틴과 티옥트산 칼륨염의 복합염, 이의 제조방법 및 이를 포함하는 약학적 조성물 |
| US20110217252A1 (en) * | 2008-11-11 | 2011-09-08 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Compound useful for treating cellulite |
| EP2389931A1 (en) * | 2010-05-21 | 2011-11-30 | Raw Materials Internatinal LLC | Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant |
| US9040082B2 (en) | 2011-06-24 | 2015-05-26 | K-Pax Pharmaceuticals, Inc. | Compositions and methods for treatment of chronic fatigue |
| US8957048B2 (en) | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
| CA2858574C (en) | 2011-12-07 | 2017-05-30 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
| US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
| US20140371280A1 (en) * | 2013-03-15 | 2014-12-18 | Shinichi Okuyama | Method of treating diabetic peripheral neuropathy through amendment of pre-neuronal diabetic coagulative micro-angiopathy and neuronal deficiency of mitochondrial ATP production, and through induction of neuronal regeneration |
| US20190290609A1 (en) * | 2014-03-19 | 2019-09-26 | Epitech Group S.P.A. | Pharmaceutical composition comprising palmitoylethanolamide and l-acetylcarnitine |
| WO2016065360A1 (en) * | 2014-10-24 | 2016-04-28 | Robert Shorr | Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome |
| NZ732058A (en) | 2014-11-25 | 2023-06-30 | Allergan Inc | Stabilized omega-3 ophthalmic compositions |
| DK3277273T3 (da) * | 2015-03-31 | 2020-04-14 | Kolinpharma S P A | Sammensætning til behandling af neuropatier og/eller neuropatisk smerte |
| US11639494B2 (en) | 2015-08-24 | 2023-05-02 | Vitrolife Sweden Ab | Culture medium |
| US11998554B2 (en) * | 2018-09-10 | 2024-06-04 | URIACH ITALY S.r.l. | Composition comprising lipoic acid and vitamin D for the prevention and the treatment of neurodegenerative diseases and peripheral neuropathies |
| CN111467385B (zh) * | 2019-01-24 | 2022-05-17 | 深圳市华大农业应用研究院 | 组合物在预防或治疗神经退行性疾病中的用途 |
| US12521407B2 (en) | 2019-04-18 | 2026-01-13 | Simo Rasi | Composition for use in prevention or reduction of oxidative stress and neurodegenerative diseases |
| US12208077B2 (en) | 2021-04-06 | 2025-01-28 | Celagenex Research (India) Pvt. Ltd. | Synergistic composition for potentiating stabilized ATP |
| CN112999220B (zh) * | 2021-04-07 | 2022-12-13 | 中国人民解放军南部战区总医院 | α-硫辛酸在作为和/或制备金属β-内酰胺酶抑制剂中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5668117A (en) * | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
| WO1997002041A1 (en) * | 1995-07-03 | 1997-01-23 | Crandall Wilson T | Transdermal and oral treatment of androgenic alopecia |
| IT1283967B1 (it) * | 1996-03-29 | 1998-05-07 | Sigma Tau Ind Farmaceuti | Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi |
| US5977162A (en) * | 1996-09-16 | 1999-11-02 | Seidman; Michael D. | Therapeutic treatment for auditory function |
| JP2001511153A (ja) * | 1997-02-04 | 2001-08-07 | ブイ． コスバブ，ジョン | 血管変性性疾患の予防および処置のための組成物および方法 |
| IT1291113B1 (it) | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizione nutritiva terapeutica per soggetti affetti da diabete mellito |
| US5916912A (en) | 1997-06-16 | 1999-06-29 | The Regents Of The University Of California | Dietary composition for enhancing metabolism and alleviating oxidative stress |
-
1998
- 1998-09-01 IT IT1998RM000566A patent/IT1302307B1/it active IP Right Grant
-
1999
- 1999-08-06 MA MA25719A patent/MA25284A1/fr unknown
- 1999-08-19 CA CA002341973A patent/CA2341973C/en not_active Expired - Lifetime
- 1999-08-19 AU AU53871/99A patent/AU773424B2/en not_active Expired
- 1999-08-19 JP JP2000567099A patent/JP4361215B2/ja not_active Expired - Lifetime
- 1999-08-19 CN CN99810437A patent/CN1315835A/zh active Pending
- 1999-08-19 ES ES99939612T patent/ES2188214T5/es not_active Expired - Lifetime
- 1999-08-19 HU HU0102909A patent/HU229165B1/hu unknown
- 1999-08-19 AT AT99939612T patent/ATE228312T1/de active
- 1999-08-19 BR BR9913288-5A patent/BR9913288A/pt not_active Application Discontinuation
- 1999-08-19 EP EP99939612A patent/EP1112005B2/en not_active Expired - Lifetime
- 1999-08-19 PT PT99939612T patent/PT1112005E/pt unknown
- 1999-08-19 TR TR2001/00610T patent/TR200100610T2/xx unknown
- 1999-08-19 US US09/786,153 patent/US6365622B1/en not_active Expired - Lifetime
- 1999-08-19 EE EEP200100113A patent/EE200100113A/xx unknown
- 1999-08-19 CZ CZ2001541A patent/CZ2001541A3/cs unknown
- 1999-08-19 SK SK263-2001A patent/SK2632001A3/sk unknown
- 1999-08-19 IL IL14143599A patent/IL141435A0/xx unknown
- 1999-08-19 WO PCT/IT1999/000268 patent/WO2000011968A1/en not_active Ceased
- 1999-08-19 PL PL346318A patent/PL212737B1/pl unknown
- 1999-08-19 DE DE69904208T patent/DE69904208T3/de not_active Expired - Lifetime
- 1999-08-19 DK DK99939612.0T patent/DK1112005T4/da active
- 1999-08-19 KR KR1020017002527A patent/KR20010079699A/ko not_active Withdrawn
- 1999-08-19 HK HK02101323.4A patent/HK1039730A1/zh unknown
- 1999-08-30 AR ARP990104347A patent/AR022076A1/es unknown
- 1999-08-30 TN TNTNSN99163A patent/TNSN99163A1/fr unknown
-
2001
- 2001-02-16 IS IS5850A patent/IS5850A/is unknown
- 2001-02-26 NO NO20010954A patent/NO20010954L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9913288A (pt) | Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóico | |
| BR9911440A (pt) | Composição para a prevenção e/ou tratamento de osteoporose e alterações devido à sìndrome de menopausa | |
| BR9912179A (pt) | Composição neuroprotetora para a prevenção e/ou tratamento de alterações nervosas e do comportamento devido a estados de ansiedade ou depressão | |
| BR0010113A (pt) | Preparações para uso externo na pele | |
| BR0112799A (pt) | Composição farmacêutica, processo para preparação e utilização da mesma, conjunto e processo para tratamento de obesidade, utilização de um inibidor de lìpase e de um sequestrante de ácido de bìlis e processo de tratamento ou prevencão de efeitos colaterais gastrointestinais | |
| BR0206381A (pt) | Derivados do ácido fumárico como inibidor de nf-kappab | |
| BR9814327A (pt) | Compostos de tiouréia e benzamida, composições e pro-cessos para tratamento ou prevenção de doenças infla-matórias e arteriosclerose | |
| BRPI0407922A (pt) | derivados de isoquinolina e métodos de uso destes | |
| BRPI0512220A (pt) | método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto | |
| BR9915918A (pt) | Combinação de carnitinas e resveratrol para prevenção ou tratamento de distúrbios cerebrais ou de envelhecimento | |
| BRPI0410170A (pt) | preparação e uso de derivados de ácido aril alquìlico para o tratamento de obesidade | |
| BRPI0415121A (pt) | material particulado, forma de dosagem sólida, método para fabricar a mesma, e, uso de um material particulado ou de uma forma de dosagem sólida | |
| BR0107157A (pt) | Diagnose e tratamento de condições cardiovasculares | |
| MXPA04005376A (es) | Composiciones farmaceuticas y sus usos. | |
| BR0013122A (pt) | Ciclobenzaprina para tratamento de distúrbio de ansiedade generalizado e composições de ciclobenzaprina | |
| BR9916197A (pt) | Método para o tratamento de isquemia cerebral e uso de eritropoietina ou derivados de eritropoietina para o tratamento de isquemia cerebral | |
| BRPI0411361A (pt) | composições oftálmicas contendo uma combinação sinérgica de dois polìmeros | |
| BR0210013A (pt) | Gel oftálmico de pirenzepina | |
| BR0006045A (pt) | Composição que compreende uma carnitina e glutationa, útil para aumentar a absorção de glutationa e para sinergizar seus efeitos | |
| BRPI0408477A (pt) | compostos de éster de fosfato/sulfato e composições farmacêuticas para inibir a nima de interação com proteìna (pin 1) e uso dos mesmos | |
| BR0312845A (pt) | Tetratiomolibdato de tetrapropilamÈnio e compostos relacionados para terapias antiangiogênicas | |
| BR0112337A (pt) | Derivados de fosfolipìdeos de ácido valpróico e suas misturas | |
| BRPI0411176A (pt) | combinação farmacêutica consistindo de modafinil e outra droga | |
| BR9912703A (pt) | Composição antioxidante, antiprolìfera, compreendendo uma carnitina e um carotenóide | |
| BR9814214A (pt) | Composição com ácido azeláico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/385 (2006.01), A23L 33/12 (2016.0 |